Data / Drug companies / Drospirenone and ethinyl estradiol
Drospirenone and ethinyl estradiol: 16 companies and 22 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Drospirenone and ethinyl estradiol is listed in the FDA National Drug Code Directory by 16 companies, with 22 products in commercial distribution. 20 of the products (90.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are kit, and the newest product started marketing on January 26, 2026.
The request: Get every company that lists drospirenone and ethinyl estradiol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 22
- Generic (ANDA) products
- 20 (90.9%)
- Application numbers
- 14
- Brand names
- Syeda, Yaz, Nikki, Jasmiel, Zumandimine, Yasmin, Lo-Zumandimine, Vestura
- openFDA record search
- api.fda.gov
Companies that list drospirenone and ethinyl estradiol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 2 | kit | Generic drugs (ANDA) | March 25, 2016 |
| Aurobindo Pharma Limited | 2 | kit | Generic drugs (ANDA) | March 26, 2018 |
| Bayer HealthCare Pharmaceuticals Inc. | 2 | kit | New drug applications (NDA) | March 16, 2006 |
| Camber Pharmaceuticals, Inc. | 2 | kit | Generic drugs (ANDA) | January 24, 2020 |
| Glenmark Pharmaceuticals Inc., USA | 2 | kit | Generic drugs (ANDA) | March 25, 2016 |
| Lupin Pharmaceuticals, Inc. | 2 | kit | Generic drugs (ANDA) | April 15, 2022 |
| Afaxys Pharma, LLC | 1 | kit | Generic drugs (ANDA) | February 27, 2018 |
| Apotex Corp. | 1 | kit | Generic drugs (ANDA) | January 26, 2026 |
| Bryant Ranch Prepack | 1 | kit | Generic drugs (ANDA) | December 1, 2017 |
| Mylan Pharmaceuticals Inc. | 1 | kit | Generic drugs (ANDA) | August 28, 2015 |
| Naari Pte Limited | 1 | kit | Generic drugs (ANDA) | April 5, 2023 |
| NorthStar RxLLC | 1 | kit | Generic drugs (ANDA) | September 1, 2025 |
| Proficient Rx LP | 1 | kit | Generic drugs (ANDA) | August 17, 2015 |
| Redpharm Drug | 1 | kit | Generic drugs (ANDA) | April 15, 2022 |
| Teva Pharmaceuticals, Inc. | 1 | kit | Generic drugs (ANDA) | November 6, 2024 |
| Xiromed, LLC | 1 | kit | Generic drugs (ANDA) | December 1, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 22 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 20 | 90.9% |
| New drug applications (NDA) | 2 | 9.1% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.